LivaNova - About the company
LivaNova is a public company based in London (United Kingdom), founded in 2015. It operates as a Provider of cardiac and neurological therapeutic devices. LivaNova has raised an undisclosed amount in funding. The company has 26 active competitors, including 5 funded and 6 that have exited. Its top competitors include companies like NeuroPace, INBRAIN Neuroelectronics and Cyberonics.
Company Details
- Website
- www.livanova.com/en-us
- Social
- Email ID
- *****@LivaNova.com
- Registered Address
- Ztracená 977 75002 Přerov
Key Metrics
Founded Year
2015
Location
London, United Kingdom
Stage
Public
Latest Funding Round
Investors
Ranked
3rd among 26 active competitors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
2,690 as on Jun 30, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with LivaNova
LivaNova is associated with 6 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
HEAD & HEART s.r.o. CIN: 61975575 , Czech Republic, Active | Jun 22, 1995 | - | - | |
Leonova Group, s.r.o. CIN: 05672821 , Czech Republic, Active | Jan 03, 2017 | - | - | |
LIVANOVA PLC CIN: 1639691 , United States, Active | $1B+ (As on Dec 31, 2025) | - | - | |
LIVANOVA INDIA PRIVATE LIMITED CIN: U74140HR2015FTC133237 , India, Active | Jul 28, 2015 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 25 (As on Apr 01, 2026) | |
LivaNova PLC CIN: 9451374 , United Kingdom, Active | Dec 31, 2014 | £0 - £1M (As on Dec 31, 2024) | 68 (As on Jan 31, 2022) | |
LIVANOVA HOLDING USA, INC. CIN: 841491245 , United States, Active | Dec 31, 1999 | - | 1284 (As on Dec 31, 2019) | - |
LivaNova's IPO details
LivaNova got listed on Feb 10, 1993.
Click here to take a look at LivaNova's IPO in detail
Sign up to download LivaNova's company profile
LivaNova's funding and investors
LivaNova has raised funding over 6 rounds. Its first funding round was on Dec 15, 2014. Its latest funding round was a Grant (prize money) round on Jan 01, 2021 for $*****. 1 investor participated in its latest round. LivaNova has 5 institutional investors.
Here is the list of recent funding rounds of LivaNova:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 01, 2021 | 2680627 | Grant (prize money) | 4256501 | 9789704 | 5178604 | 4814583 |
Apr 2019 | 2278237 | Conventional Debt | 2820262 | 3847666 | 4101518 | |
Apr 2019 | 1853635 | Grant (prize money) | 9694285 | 4654634 | 5228273 |
Access funding benchmarks and valuations. Sign up today!View details of LivaNova's funding rounds and investors
LivaNova's founders and board of directors
Founder? Claim ProfileLivaNova's employee count trend
LivaNova has 2,690 employees as of Jun 26. Here is LivaNova's employee count trend over the years:
Uncover LivaNova's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
LivaNova's Competitors and alternates
Top competitors of LivaNova include NeuroPace, INBRAIN Neuroelectronics and Cyberonics. Here is the list of Top 10 competitors of LivaNova, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NeuroPace 1997, Mountain View (United States), Public | Developer of implantable neurostimulation system for epilepsy treatment | $264M | 66/100 | |
2nd | INBRAIN Neuroelectronics 2019, Barcelona (Spain), Series B | Developer of implantable neurotechnology for decoding and modulating brain activity | $82.8M | 65/100 | |
3rd | LivaNova 2015, London (United Kingdom), Public | Provider of cardiac and neurological therapeutic devices | - | 65/100 | |
4th |  Cyberonics 1987, Houston (United States), Public | Vagus nerve stimulation device for epilepsy and treatment resistant depression | - | - | 46/100 |
5th | Engage Therapeutics 2017, Summit (United States), Acquired | Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures | $30.6M | 42/100 | |
6th |  Cadence Neuroscience 2016, Redmond (United States), Series B | Developer of medical devices for treating neurological disorders | $41M | 42/100 | |
7th | NeuroVice 2016, Cary (United States), Funding Raised | Developing innovative oral health solutions for seizure-related injuries and improving patient experience | - | - | 38/100 |
8th | OceansBIo 2021, Changwon (South Korea), Public | Developer of electroceutical devices for epilepsy treatment | - | 33/100 | |
9th | Portfolio of devices and tools for neurological surgery | - | 33/100 | ||
10th |  NightWatch 2013, Leiden (Netherlands), Series A | Provider of wearable device for epilepsy seizure detection during sleep | - | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on LivaNova's competitors? Click here to see the top ones
LivaNova's Investments and acquisitions
LivaNova has made 6 investments in companies including ShiraTronics and Cadence Neuroscience. LivaNova has also acquired 4 companies including ALung and TandemLife.Here is the list of investments & acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 11, 2023 | Investments | 2019 | Minneapolis (United States) | |
Feb 28, 2023 | Investments | 2016 | Redmond (United States) | |
May 05, 2022 | Acquisition | 1997 | Pittsburgh (United States) |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by LivaNova
Reports related to LivaNova
Here is the latest report on LivaNova's sector:
News related to LivaNova
Filter this listMedia has covered LivaNova for a total of 23 events in the last 1 year, 11 of them have been about company updates and 4 about people movement.
•
Jette Nygaard-Andersen Joins LivaNova Board as DirectorMedical Product Outsourcing•Aug 27, 2026•Coloplast, LivaNova
•
LivaNova PLC Non-GAAP EPS of $1.26 beats by $0.17, revenue of $390.6M beats by $10.02M (LIVN:NASDAQ)Seeking Alpha•Aug 05, 2026•LivaNova
•
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) InvestorsSimply Wall St•Jul 07, 2026•LivaNova
•
Vagus Nerve Stimulation Has a Profound Impact on Severe Depression, Major Trial FindsScienceAlert•Jul 03, 2026•LivaNova
•
•
•
•
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business UnitBusiness Wire•May 21, 2026•LivaNova
•
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS GuidanceBusiness Wire•May 06, 2026•LivaNova
•
Peregrine Capital Management LLC Invests $3.83 Million in LivaNova PLCMarketBeat•Apr 25, 2026•LivaNova, Peregrine Capital Management
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about LivaNova
Explore our recently published companies
- Fuji Addict - Unfunded company
- Mediscoop - Boulogne-Billancourt based, 2004 founded, Unfunded company
- DU Express - India based, 2015 founded, Unfunded company
- Orion Carport - Commerce based, Unfunded company
- Nutshell Advertising - India based, 2014 founded, Unfunded company
- SuperDataScience - 2015 founded, Unfunded company
